Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.6.6 has been added on the page, replacing the previous v3.6.5. This reflects a build update without changing the study details presented.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.6.5 added, replacing the previous v3.6.4. This indicates a small platform update or patch applied to the site.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page, indicating a deployment update. This appears to be a deployment-level metadata change with no modification to the study details or visible content.SummaryDifference0.0%

- Check59 days agoChange DetectedNew update dates (2026-07-02, 2026-07-01, 2026-06) were added to the study's record history, and older dates (2026-06-24, 2026-06-23, 2026-02) were removed. This describes changes to the record's revision timeline and update history.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now includes the Arm I dosing schedule and treatment duration, MRI/blood collection procedures, and lists a participating site, plus the addition of MTD/RP2D and EFS endpoints, quality-of-life measures, and other trial details.SummaryDifference0.3%

- Check80 days agoChange DetectedAdded recruitment status notice 'No longer looking for participants' and new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with a page revision indicator 'Revision: v3.6.0'. Adjusted the heading from 'Intervention / Treatment' to 'Intervention/Treatment' and removed the older revision tag 'Revision: v3.5.5'.SummaryDifference0.2%

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.